Their innovative ideas hold promise in solving two of healthcare’s most vexing problems: the nursing shortage and wound care. And Johnson & Johnson is helping them make their high-tech dreams a reality.
Algorithms, artificial intelligence, machine learning and other technologies are transforming the way physicians identify, treat and manage diseases. Here’s how Johnson & Johnson is putting the latest tools to work.
Should we be forgoing regular checkups during the pandemic? Is it safe to go to the hospital for surgery? A Johnson & Johnson expert shares the answers—and offers guidance on how best to make healthcare decisions during these uncertain times.
Learn how J&J landed on the global corporate reputation list for the 20th year in a row and ranked #1 on the Pharmaceutical Industry list for the ninth consecutive year.
As the pandemic spread, many young people experienced anger, stress—even depression. But a Save the Children initiative supported by Johnson & Johnson is teaching them how to manage their difficult emotions.
How can you tell which virus is causing your cough or fever? Is it too late to get a flu shot if you haven't? A Johnson & Johnson expert addresses these questions—and how the company is working to improve the future of flu prevention.
Respiratory syncytial virus (RSV) is normally rampant in winter—but the pandemic has changed the behavior of this common and potentially dangerous infection. For National RSV Awareness Month, learn how Johnson & Johnson is working to keep us all safer from RSV.
Learn how their revolutionary work has not only had a crucial impact on the COVID-19 pandemic but is also paving the way for potential future vaccines and treatments.
A relaunched Johnson & Johnson partnership will help ensure that many young patients get lifesaving access to HIV medicines. Meet a doctor in Kenya who explains why the program is so crucial.
For more than a century, Johnson & Johnson has used a core set of values to help build its business. Now, that sense of purpose has landed it on the Fortune ROL100, a new ranking of corporate leadership.
Johnson & Johnson's 2020 Health for Humanity Report details the progress it's made in the past five years in driving sustainable social, environmental and economic change around the globe. Now the company's looking ahead to the next five.
Despite being preventable and curable, tuberculosis is one of the world’s deadliest infectious diseases—and COVID-19 is making it even harder to diagnose and treat it. Enter these healthcare visionaries, who've made it their mission to move the world closer to the goal of ending tuberculosis.